WisdomInterface
WisdomInterface
May 13, 2022
1 min read

Accelerate clinical trial coordination with an API-led strategy

COVID-19 has placed a significant emphasis on the safety and efficiency of clinical trials for life-saving vaccines and therapies. However, clinical trials represent one of the most significant expenses for life sciences organizations, and most trial operations are manual and disconnected. In response, pharmaceutical companies have accelerated their adoption of digital technologies to survive a global pandemic and spur innovation in response to the expectations placed on their industry.

Join us to see how MuleSoft is partnering with the world’s leading pharmaceutical organizations, like IQVIA, to accelerate decentralized clinical trials in an unpredictable and ever-changing landscape. Learn how to:

  • Automate manual processes and scale enterprise-wide automation
  • Provide comprehensive, real-time insights to trial stakeholders
  • Drive collaboration across various investigators and CROs
  • Orchestrate a patient-centric clinical trials platform

Presented by:

Alexa Cushman, Director of Industry Marketing – Healthcare and Life Sciences, MuleSoft

Nagaraja Srivatsan (Sri), SVP and CDO, IQVIA

Allegra Margolis, Director of Product Marketing – Industry, MuleSoft

Vishnu Samavedula, Senior Solutions Engineer, MuleSoft

ITWebinar

    Watch Now:








    By submitting this form, you agree to have your contact information, including email, passed on to Salesforce for the purpose of following up on your interests.

    SUBSCRIBE

      Subscribe for more insights



      By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy.

      No spam, we promise. You can update your email preference or unsubscribe at any time and we'll never share your details without your permission.

        Subscribe for more insights



        By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy.

        No spam, we promise. You can update your email preference or unsubscribe at any time and we'll never share your details without your permission.